Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 1992

Conditions

Herpes SimplexHIV Infections

Interventions

DRUG

Trifluridine

DRUG

Bacitracin zinc/Polymyxin B sulfate

Trial Locations (8)

NY Univ. HIV/AIDS CRS, New York

Johns Hopkins Adult AIDS CRS, Baltimore

Ucsf Aids Crs, San Francisco

University of Colorado Hospital CRS, Aurora

Cook County Hosp. CORE Ctr., Chicago

Northwestern University CRS, Chicago

Rush Univ. Med. Ctr. ACTG CRS, Chicago

Washington U CRS, St Louis